• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antisense Therapeutics Ltd

+ Add to Watchlist

AWY:GR

0.079 EUR 0.003 3.66%

As of 02:08:01 ET on 09/19/2014.

Snapshot for Antisense Therapeutics Ltd (AWY)

Open: 0.079 Day's Range: 0.079 - 0.079 Volume: 0
Previous Close: 0.082 52wk Range: 0.070 - 0.132 1-Yr Rtn: -28.18%

Stock Chart for AWY

No chart data available.
  • AWY:GR 0.079
  • 1M
  • 1Y
0.082
Interactive AWY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AWY

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 11.38
Shares Outstanding (M) 144.10
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AWY

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for AWY

Antisense Therapeutics Limited develops and markets drugs for treatment of diseases like psoriasis, multiple sclerosis, autoimmune, cancer, metabolic and cardiovascular. The drugs are based on small synthetic genetic molecules. The Company has collaboration with Isis Pharmaceuticals in the United States, which provides the Company access to drug development technology.

Mark P DiamondCEO/Managing DirectorPhillip HainsCFO/Secretary
More Company Profile & Key Executives for AWY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil